Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Ruria NambaJeffrey P Gregg

Abstract

Rapamycin has been shown to have antitumor effects in various tumor models. To study the effect of rapamycin at different stages of breast cancer development, we used two unique mouse models of breast cancer with activated phosphatidylinositol 3-kinase (PI3K) pathway. Met-1 tumors are highly invasive and metastatic, and mammary intraepithelial neoplasia-outgrowths (MIN-O), a model for human ductal carcinoma in situ, are transplantable premalignant mammary lesions that develop invasive carcinoma with predictable latencies. Both of these models were derived from mammary lesions in Tg(MMTV-PyV-mT) mice. Met-1 tumors were used to study the effect of rapamycin treatment on invasive disease. Transplanted MIN-O model was used to study the effect of rapamycin on premalignant mammary lesions. Animals were in vivo micro-positron emission tomography imaged to follow the lesion growth and transformation to tumor during the treatment. Cell proliferation, angiogenesis, and apoptosis was assayed by immunohistochemistry. Rapamycin inhibited in vitro tumor cell proliferation and in vivo Met-1 tumor growth. The growth inhibition was correlated with dephosphorylation of mammalian target of rapamycin (mTOR) targets. Rapamycin treatment significant...Continue Reading

References

May 8, 1998·Physics in Medicine and Biology·J QiT H Farquhar
Jun 11, 1998·The Journal of Biological Chemistry·S HashemolhosseiniS Ferrari
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·R T PetersonS L Schreiber
May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kartiki V DesaiJeffrey E Green
Sep 6, 2002·The American Journal of Pathology·Andrea RosnerRobert D Cardiff
Apr 16, 2004·Breast Cancer Research : BCR·Katayoun Alavi JessenJeffrey P Gregg
May 4, 2004·Nature Reviews. Cancer·Mary-Ann Bjornsti, Peter J Houghton
Jul 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Craig K AbbeySimon R Cherry
Aug 21, 2004·Breast Cancer Research : BCR·Hetty Carraway, Manuel Hidalgo
Sep 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L A DeGraffenriedM Hidalgo
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wallace H MondesireFunda Meric-Bernstam
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anne BoulayHeidi A Lane
Sep 1, 2005·Clinical & Experimental Metastasis·Alexander D BorowskyJeffrey P Gregg

❮ Previous
Next ❯

Citations

Nov 9, 2006·Journal of Mammary Gland Biology and Neoplasia·Craig K AbbeySimon R Cherry
Dec 17, 2009·Gastroentérologie Clinique Et Biologique·J Dumortier
Oct 12, 2010·Molecular Pharmaceutics·Azadeh KheirolomoomKatherine W Ferrara
Nov 17, 2011·Molecular Pharmaceutics·Joeri KuilFijs W B van Leeuwen
Mar 25, 2011·Nature Reviews. Cancer·M Christine HollanderPhillip A Dennis
Jun 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·David B ShackelfordReuben J Shaw
Oct 21, 2010·Physics in Medicine and Biology·Jinxiu Cheng-Liao, Jinyi Qi
Mar 31, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tara C GangadharMark J Ratain
May 20, 2011·Cancer Prevention Research·Laura M LashingerStephen D Hursting
Jul 8, 2011·Cancer Prevention Research·Mohammad Athar, Levy Kopelovich
Jun 24, 2008·BMC Cancer·Elena V SvirshchevskayaLyuba Varticovski
Aug 2, 2012·Journal of Biomedicine & Biotechnology·Massimiliano Cazzaniga, Bernardo Bonanni
Aug 21, 2008·Nutrition Reviews·Joshua W MillerRalph Green
Jul 8, 2011·Cancer Prevention Research·L Allyson CheckleyJohn DiGiovanni
Jul 26, 2008·Journal of Mammary Gland Biology and Neoplasia·Lawrence J T Young
Jul 13, 2006·Expert Review of Anticancer Therapy·Niklaus G SchaeferChristoph Renner
Mar 13, 2013·Expert Review of Molecular Diagnostics·Hitchintan KaurRaymond R Mattingly
May 14, 2010·Cancer Treatment Reviews·Laura G EstévezIgnasi Tusquets
May 2, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marius RaicaDomenico Ribatti
Jun 6, 2009·Basic & Clinical Pharmacology & Toxicology·Geng-Ruei ChangFrank Chiahung Mao
Oct 31, 2012·Biochemical Pharmacology·Balindiwe J N SishiAnna-Mart Engelbrecht
Apr 7, 2010·The American Journal of Pathology·Vladimir N AnisimovMikhail V Blagosklonny
Mar 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E E W CohenM J Ratain
Sep 29, 2009·The Journal of Steroid Biochemistry and Molecular Biology·Hironobu SasanoTakashi Suzuki
Apr 17, 2007·Advances in Cancer Research·Robert D Cardiff, Nicholas Kenney
Mar 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea DeCensiAliana Guerrieri-Gonzaga
May 15, 2013·Therapeutic Drug Monitoring·Jeffrey R ScottAlexander A Vinks
Jun 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Tengku Ahmad Damitri Al-Astani Tengku DinHasnan Jaafar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.